KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortization Amortization Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Bausch Health Companies (BHC) Gains from Investment Securities (2016 - 2026)

Bausch Health Companies' Gains from Investment Securities history spans 18 years, with the latest figure at $34.0 million for Q1 2026.

On a quarterly basis, Gains from Investment Securities rose 112.5% to $34.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $42.0 million, a 50.0% increase, with the full-year FY2025 number at $24.0 million, down 7.69% from a year prior.
Gains from Investment Securities hit $34.0 million in Q1 2026 for Bausch Health Companies, up from $5.0 million in the prior quarter.
Over the last five years, Gains from Investment Securities for BHC hit a ceiling of $34.0 million in Q3 2022 and a floor of -$29.0 million in Q2 2022.
Historically, Gains from Investment Securities has averaged $8.7 million across 5 years, with a median of $5.0 million in 2024.
The widest YoY moves for Gains from Investment Securities: up 1033.33% in 2022, down 207.41% in 2022.
Tracing BHC's Gains from Investment Securities over 5 years: stood at $1.0 million in 2022, then changed by 0.0% to $1.0 million in 2023, then skyrocketed by 200.0% to $3.0 million in 2024, then surged by 66.67% to $5.0 million in 2025, then surged by 580.0% to $34.0 million in 2026.
Business Quant data shows Gains from Investment Securities for BHC at $34.0 million in Q1 2026, $5.0 million in Q3 2025, and $3.0 million in Q2 2025.